ResMed (NYSE: RMD) director sells 2,000 shares under Rule 10b5-1 plan

ResMed Inc. director Peter C. Farrell sold 2,000 shares of ResMed Common Stock at $225.00 per share, totaling $450,000, under a pre-arranged Rule 10b5-1 trading plan. Following this transaction, Farrell directly holds 60,773 shares. This sale was reported via a Form 4 SEC filing, indicating a moderate filing impact and negative sentiment.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin